The Effects of Body Acupuncture on Obesity: Anthropometric Parameters, Lipid Profile, and Inflammatory and Immunologic Markers

Table 3

Comparison of changes in clinical and biochemical characteristics of body acupuncture.

Variable	Real group				Sham group
	1st period	2nd period	Whole period	𝑃 value; 1 v. 2	1st period	2nd period	Whole period	𝑃 value; 1 v. 2	𝑃 value; R. v. S.
									1st 𝑃: 0.019
Weight (kg)	2.98±0.22	1.22±0.18	4.15±0.37	0.000	2.21±0.23	0.29±0.29	2.40±0.60	0.001	2nd 𝑃: 0.006
									3rd 𝑃: 0.012
									1st 𝑃: 0.632
Body fat (%)	0.90±0.18	−1.39±1.72	−0.38±1.70	0.177	0.77±0.20	0.43±0.40	1.22±0.35	0.507	2nd 𝑃: 0.326
									3rd 𝑃: 0.377
									1st 𝑃: 0.038
BMI (Kg/m^2)	1.16±0.09	0.29±0.10	1.47±0.14	0.000	0.86±0.10	0.47±0.27	1.24±0.16	0.221	2nd 𝑃: 0.523
									3rd 𝑃: 0.294
									1st 𝑃: 0.000
WC (cm)	7.05±0.60	1.76±0.40	8.93±0.79	0.000	4.07±0.52	−0.50±0.93	3.97±0.92	0.000	2nd 𝑃: 0.020
									3rd 𝑃: 0.000
									1st 𝑃: 0.000
HC (cm)	7.16±0.40	1.63±0.37	8.70±0.56	0.000	3.76±0.56	1.17±0.68	5.49±0.64	0.011	2nd 𝑃: 0.538
									3rd 𝑃: 0.000
									1st 𝑃: 0.926
WC/HC ratio	0.007±0.006	0.003±0.004	0.015±0.008	0.384	0.006±0.005	−0.01±0.008	−0.005±0.008	0.106	2nd 𝑃: 0.064
									3rd 𝑃: 0.095
									1st 𝑃: 0.780
FBS (mg/dL)	−2.70±1.39	−0.70±3.43	−3.61±2.98	0.611	−2.08±1.74	2.83±2.03	0.45±1.58	0.170	2nd 𝑃: 0.388
									3rd 𝑃: 0.237
									1st 𝑃: 0.001
TC (mg/dL)	25.35±2.60	7.52±2.99	32.62±3.59	0.000	10.98±3.58	6.80±3.44	18.51±4.46	0.456	2nd 𝑃: 0.873
									3rd 𝑃: 0.014
									1st 𝑃: 0.002
TG (mg/dL)	19.97±3.55	5.73±2.52	25.97±5.53	0.003	1.48±5.85	17.19±6.84	21.82±7.57	0.530	2nd 𝑃: 0.200
									3rd 𝑃: 0.357
									1st 𝑃: 0.974
HDL-C (mg/dL)	4.02±0.97	−16.07±2.88	−12.12±3.12	0.000	3.97±0.99	−13.15±2.80	−10.64±3.11	0.000	2nd 𝑃: 0.471
									3rd 𝑃: 0.739
									1st 𝑃: 0.017
LDL-C (mg/dL)	17.17±2.23	15.19±2.96	31.85±3.13	0.734	9.03±2.55	7.22±2.80	15.34±3.29	0.581	2nd 𝑃: 0.054
									3rd 𝑃: 0.000
									1st 𝑃: 0.000
Anti-HSP27 Antibody	0.03(0.01-0.06)	0.02(0.0-0.04)	0.05(0.02-0.08)	0.083	0.01(−0.01-0.02)	−0.01(−0.02-0.01)	0.0(−0.01-0.02)	0.028	2nd 𝑃: 0.000
									3rd 𝑃: 0.000
									1st 𝑃: 0.000
Anti-HSP60 Antibody	0.03(0.02-0.05)	0.02(0.01-0.05)	0.06(0.04-0.09)	0.114	0.01(−0.007-0.02)	0.0(−0.01-0.02)	0.01(−0.01-0.02)	0.264	2nd 𝑃: 0.000
									3rd 𝑃: 0.000
									1st 𝑃: 0.003
Anti-HSP65 Antibody	0.02(−0.01-0.05)	0.03(0.01-0.05)	0.05(0.03-0.08)	0.370	0.01(−0.01-0.02)	0.005(−0.01-0.017)	0.01(−0.01-0.02)	0.569	2nd 𝑃: 0.000
									3rd 𝑃: 0.000
									1st 𝑃: 0.000
Anti-HSP70 Antibody	0.02(0.01-0.04)	0.02(0.01-0.04)	0.05(0.03-0.07)	0.936	0.01(−0.01-0.02)	−0.005(−0.02-0.01)	0.0(−0.01-0.02)	0.096	2nd 𝑃: 0.000
									3rd 𝑃: 0.000
									1st 𝑃: 0.790
hs-CRP (mg/dL)	0.0(−0.63-0.94)	0.90(0.15-1.7)	1.06(0.18-1.47)	0.024	0.0(−0.58-0.75)	0.8(0.1-1.60)	0.62(0.13-1.39)	0.226	2nd 𝑃: 0.691
									3rd 𝑃: 0.256

R: real; S: sham; BMI: body mass index; WC: waist circumference; HC: hip circumference; FBS: fasting blood sugar; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol, DBP: diastolic blood pressure, SBP: systolic blood pressure. Values are expressed as mean ± SEM, or median and interquartile range. Paired t-test and Wilcoxon signed ranked test were used for comparison between first and second periods for normally and nonnormally distributed data, respectively. Independent sample t-test (for normally distributed data) and Mann-Whitney test (for non-normally distributed data) were used for comparison 2 groups.